Nedosiran

Nedosiran (DCR-PHXC) is an RNA interference (RNAi) targeting lactate dehydrogenase (LDH). Nedosiran represents an impactful potential therapeutic for primary hyperoxaluria (PH) with end-stage renal disease (ESRD). Nedosiran is a GalNAc-dsRNA conjugate.
Read more
€0.00 (tax incl.)
Reference:
HY-132606
Product Details
HY-132606

Data sheet

Size
Multiple sizes
Reactivity
Small Interfering RNA (siRNA)
Application
Metabolism-protein/nucleotide metabolism
CAS
2266591-83-5

Menu

Settings